You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
DexCom Returns vs. S&P
|1 Year||5 Year||5 Year Annualized||Since IPO|
DexCom Company Info
A medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for people with diabetes.
News & Analysis
Don't overlook these growth plays.
Choosing an exchange-traded fund can provide diversification and possibly less volatility for your portfolio.
The new year is here, and with it, more opportunities to invest in wonderful companies.
This company offers products that are essential to the well-being of its customers.
Opportunities are abundant right now, even if share prices are down.
These growing businesses are just starting to see the beginning of their long-term potential.
A down market doesn't mean you should hit pause on adding new stocks to your portfolio.
DXCM earnings call for the period ending September 30, 2022.
DXCM earnings call for the period ending June 30, 2022.
DXCM earnings call for the period ending March 31, 2022.
DXCM earnings call for the period ending December 31, 2021.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.